PFG Private Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-130
Closed -$10.7K – 238
2023
Q4
$10.7K Sell
130
-184
-59% -$14K 0.01% 131
2023
Q3
$24.6K Sell
314
-660
-68% -$55.3K 0.02% 157
2023
Q2
$85.8K Sell
974
-5
-0.5% -$430 0.05% 127
2023
Q1
$78.9K Buy
979
+226
+30% +$18.4K 0.05% 130
2022
Q4
$59K Sell
753
-170
-18% -$13.8K 0.04% 131
2022
Q3
$75K Hold
923
– – 0.05% 114
2022
Q2
$83K Buy
923
+6
+0.7% +$608 0.05% 125
2022
Q1
$102K Buy
917
+915
+45,750% +$96.7K 0.05% 123
2021
Q4
$0 Buy
+2
New +$232 ﹤0.01% 330

Other funds holding MDT

PFG Private Wealth Management's MDT Position: Q1 2024 in Review

PFG Private Wealth Management sold out of Medtronic (MDT) in Q1 2024, closing a stake of 130 shares — an estimated $10.7K sold.

PFG Private Wealth Management first reported a position in MDT in Q4 2021 and held it in 9 quarters. The position peaked at $102K in Q1 2022. 2,081 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • PFG Private Wealth Management reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • PFG Private Wealth Management sold 130 Medtronic shares in Q1 2024, an estimated $10.7K.
  • PFG Private Wealth Management first reported a position in Medtronic in Q4 2021 and held it in 9 quarters.
  • PFG Private Wealth Management's Medtronic position peaked at $102K in Q1 2022.
  • 2,081 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on PFG Private Wealth Management's 13F filing for Q1 2024, filed 23 Apr 2024.